Hpv cancer of the neck, Meniu de navigare Cancer hpv head and neck

Hpv cancer oropharynx, Hpv positive oropharyngeal cancer, Hpv positive oropharyngeal cancer - Oropharyngeal cancer hpv

Conținutul

    hpv cancer oropharynx

    Predictive value of HPV p53 and p16 in the prognosis of oropharyngeal cancer. Source: ORL. The increasing incidence of oropharyngeal cancers has led the medical scientific world to look for new etiologies, in addition to the traditional ones alcohol and tobacco consumption.

    hpv cancer oropharynx

    Thus, it has been shown that the human papillomavirus HPV brings changes in the human DNA that affect the cell cycle, leading to an aberrant proliferation of tumor cells by altering the production of p53 and p16 proteins. Materials and method. Results and discussion.

    hpv cancer oropharynx

    A statistical processing of the obtained data was performed, which allowed the hpv cancer oropharynx of the degree of involvement of HPV infection in the prognosis of these cases and in the choice of treatment. The results of the study were consistent with those published in the literature, and the hpv cancer oropharynx of HPV Hpv cancer oropharynx from the tumor should change the treatment plan for oropharyngeal SCC. The development of new national oncological guidelines related to this pathology would lead to an improvement in the survival rate and the quality of life of patients.

    Copyright of ORL. However, users may print, download, or email articles for individual use. This abstract may be abridged.

    hpv cancer oropharynx

    No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.

    hpv cancer oropharynx

    Important User Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, non-commercial use. However, remote access to EBSCO's databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction or avoidance for a non-subscribing institution.

    hpv cancer oropharynx